CERT (Certara) Total Operating Expense: $249.4 Mil (TTM As of Mar. 2026)


CERT Certara Inc CERT
54 GF Score
Price $5.80
GF Value $13.40
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Certara Total Operating Expense?

Certara CERT +6.38% 54 Total Operating Expense is $249.4 Mil as of Mar. 2026. GuruFocus rates CERT with a GF Score™ of 54/100 and a GF Value™ of $13.40 (Possible Value Trap). The stock has 2 warning signs investors should review.

Certara's Total Operating Expense for the three months ended in Mar. 2026 was $69.6 Mil. Certara's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $249.4 Mil.

Certara Total Operating Expense Related Terms

Certara Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Certara's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Certara Total Operating Expense Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 160.91 170.55 207.11 232.36 236.70

Certara Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.86 54.30 61.89 63.64 69.60
CERT
54GF Score
Certara Inc CERT
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Certara Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $249.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $249.4 Mil mean?
Certara (CERT) has a Total Operating Expense of $249.4 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Certara and its competitors.
Is Certara's Total Operating Expense too high?
Certara's current Total Operating Expense is $249.4 Mil. Overall, Certara has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Certara's Total Operating Expense compare to TALK and GDRX?
Certara's Total Operating Expense of $249.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Certara and its competitors. Certara's current Total Operating Expense is $249.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Based on GuruFocus' analysis, Certara (CERT) is currently considered Possible Value Trap. The stock's GF Value™ is $13.40, compared to a current price of $5.80 — trading 56.8% below its estimated fair value. The current Total Operating Expense is $249.4 Mil. Certara's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Certara (CERT), the current Total Operating Expense is $249.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Certara (CERT) Overvalued in 2026?

Based on GuruFocus' analysis, Certara stock appears to be undervalued. The current stock price of $5.80 is trading 56.8% below its estimated GF Value™ of $13.40. GuruFocus considers Certara to be Possible Value Trap.

Key valuation signals for CERT:

  • Total Operating Expense: $249.4 Mil
  • GF Value™: $13.40 vs. price of $5.80 (56.8% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Certara Business Description

Address 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
54GF Score

Get the complete analysis for CERT

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.80
Price
$13.40
GF Value